This document is a publication of a European patent application (EP2026030377A1) related to NFAT1-based therapeutics for joint diseases. The publication date is March 18, 2026. The application lists several International Patent Classification (IPC) codes, including those related to pharmaceutical preparations, viral vectors, and treatments for joint diseases.

As this is a patent publication, it does not impose direct compliance obligations on regulated entities. However, it may be of interest to pharmaceutical and biotechnology companies involved in the research and development of therapeutics for joint diseases, particularly those utilizing NFAT1 or similar biological agents. Companies should monitor the patent's prosecution status and potential grant for implications on intellectual property and market exclusivity in the designated European states.